Schonfeld Strategic Advisors’s Sensus Healthcare SRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-17,071
Closed -$118K 2481
2024
Q4
$118K Buy
+17,071
New +$125K ﹤0.01% 1828
2022
Q4
Sell
-11,800
Closed -$147K 2984
2022
Q3
$147K Sell
11,800
-2,400
-17% -$28.7K ﹤0.01% 2451
2022
Q2
$109K Buy
14,200
+4,200
+42% +$35.3K ﹤0.01% 2109
2022
Q1
$101K Buy
+10,000
New +$91.3K ﹤0.01% 2225

Other funds holding SRTS

Schonfeld Strategic Advisors's SRTS Position: Q1 2025 in Review

Schonfeld Strategic Advisors sold out of Sensus Healthcare (SRTS) in Q1 2025, closing a stake of 17,071 shares — an estimated $118K sold.

Schonfeld Strategic Advisors first reported a position in SRTS in Q1 2022 and held it in 4 quarters. The position peaked at $147K in Q3 2022. 53 funds tracked by Wall St. Rank hold SRTS as of Q1 2025.

  • Schonfeld Strategic Advisors reported no remaining Sensus Healthcare position as of Q1 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 17,071 Sensus Healthcare shares in Q1 2025, an estimated $118K.
  • Schonfeld Strategic Advisors first reported a position in Sensus Healthcare in Q1 2022 and held it in 4 quarters.
  • Schonfeld Strategic Advisors's Sensus Healthcare position peaked at $147K in Q3 2022.
  • 53 funds tracked by Wall St. Rank held Sensus Healthcare as of Q1 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2025, filed 15 May 2025.